The role of RUNX3 methylation has been intensively studied in gastric cancers (Fan et al. 2011); however, data relating CNS tumors are very limited and apply only to small groups of patients  (Avci et al. 2014). Here, RUNX3 is linked to central nervous system neoplasm.